These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38922573)
1. Identifying and Overcoming Clopidogrel Resistance: Where Do We Stand? Galli M; Pereira N J Cardiovasc Pharmacol; 2024 Sep; 84(3):316-318. PubMed ID: 38922573 [No Abstract] [Full Text] [Related]
2. Optimal antiplatelet treatment for percutaneous coronary intervention: clopidogrel vs. ticlopidine. Almsherqi ZA; McLachlan CS; Mossop P; Deng Y Int J Cardiol; 2007 Jan; 114(1):101-2. PubMed ID: 16343664 [TBL] [Abstract][Full Text] [Related]
3. Overcoming "resistance" to aspirin and clopidogrel with tirofiban: fact or fiction? Biondi-Zoccai G; Lotrionte M; Sheiban I Thromb Haemost; 2008 Oct; 100(4):521-2. PubMed ID: 18841270 [No Abstract] [Full Text] [Related]
4. Ticlopidine could be an alternative therapy in the case of pharmacological resistance to clopidogrel: a report of three cases. Aleil B; Rochoux G; Monassier JP; Cazenave JP; Gachet C J Thromb Haemost; 2007 Apr; 5(4):879-81. PubMed ID: 17403206 [No Abstract] [Full Text] [Related]
5. Identifying clopidogrel resistance during chronic therapy: the case for a biochemical approach. Horowitz JD; Chirkov YY Thromb Haemost; 2008 Oct; 100(4):519-20. PubMed ID: 18841269 [No Abstract] [Full Text] [Related]
6. Antiplatelet therapy: Personalized medicine for clopidogrel resistance? Hulot JS; Fuster V Nat Rev Cardiol; 2009 May; 6(5):334-6. PubMed ID: 19377495 [TBL] [Abstract][Full Text] [Related]
7. Clopidogrel resistance: the way forward. Ray S Indian Heart J; 2014; 66(5):530-4. PubMed ID: 25443607 [TBL] [Abstract][Full Text] [Related]
8. Aspirin and clopidogrel resistance: methodological challenges and opportunities. Gasparyan AY Vasc Health Risk Manag; 2010 Mar; 6():109-12. PubMed ID: 20448796 [TBL] [Abstract][Full Text] [Related]
9. Clopidogrel resistance: identifying and overcoming a barrier to effective antiplatelet treatment. Uchiyama S Cardiovasc Ther; 2011 Dec; 29(6):e100-11. PubMed ID: 21883990 [TBL] [Abstract][Full Text] [Related]
10. Platelet aggregation in intracranial stents may mimic in-stent restenosis. Mazighi M; Saint Maurice JP; Bresson D; Szatmary Z; Houdart E AJNR Am J Neuroradiol; 2010 Mar; 31(3):496-7. PubMed ID: 19833804 [TBL] [Abstract][Full Text] [Related]
11. Clopidogrel resistance: current aspects and future directions. Vlachojannis GJ; Dimitropoulos G; Alexopoulos D Hellenic J Cardiol; 2011; 52(3):236-45. PubMed ID: 21642072 [No Abstract] [Full Text] [Related]
12. Plasma clopidogrel metabolites and antiplatelet "resistance": back to the future. Serebruany VL Thromb Res; 2008; 122(6):725-6. PubMed ID: 18452975 [No Abstract] [Full Text] [Related]
13. Aspirin and clopidogrel resistance-a myth or reality: an update. Gupta S; Gupta MM Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315 [No Abstract] [Full Text] [Related]
14. Durability of platelet inhibition by clopidogrel. Gurbel PA; Bliden KP Am J Cardiol; 2003 May; 91(9):1123-5. PubMed ID: 12714161 [No Abstract] [Full Text] [Related]
15. [Routine platelet aggregation inhibition not useful when using acetylsalicylic acid or clopidogrel]. Kramer MC; Nieuwland R; Sturk A; de Winter RJ Ned Tijdschr Geneeskd; 2009 Jan; 153(5):190-5. PubMed ID: 19256247 [No Abstract] [Full Text] [Related]
16. Aspirin and clopidogrel resistance: an emerging clinical entity. Johns A; Fisher M; Knappertz V Eur Heart J; 2006 Jul; 27(14):1754; author reply 1754-5. PubMed ID: 16751205 [No Abstract] [Full Text] [Related]